{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:01:54Z","timestamp":1782316914487,"version":"3.54.5"},"reference-count":138,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Hypertension (HTN) is a chronic medical condition characterized by systolic blood pressure of \u2265140\u2005mmHg and diastolic blood pressure &amp;gt;80\u2005mmHg upon repeated measurements. It is one of the most common non-communicable diseases affecting 30% of the global population. Sub-Saharan Africa (SSA) has a high burden of infectious diseases, which contribute to the increased prevalence of hypertension. Furthermore, SSA has the highest number of people living with chronic infectious diseases, such as human immunodeficiency virus (HIV) and tuberculosis (TB). The pathogenesis of these conditions is associated with chronic, low-grade inflammation and immune activation that complicates various homeostatic functions, leading to increased risk of non-communicable diseases among this population. Furthermore, persistent immune activation leads to endothelial dysfunction, arterial stiffness, and altered vascular tone, which contribute to elevated and treatment-refractory blood pressure. However, immunological factors that contribute to the development and pathogenesis of hypertension remain poorly understood. Antiretroviral therapy and anti-TB medications further complicate this landscape by inducing metabolic disturbances and modulating drug metabolism, which affects the efficacy of anti-hypertensive medications. There is a paucity of data and studies reporting on immune dysregulation associated with HTN amongst people living with chronic infections such as HIV and TB. This review aims to highlight this gap in knowledge and the need for more translational research studies to improve health outcomes in hypertensive individuals living with HIV and TB in SSA. Understanding these intertwined immunological and pathophysiological mechanisms is crucial to developing targeted interventions for managing HTN, especially in this vulnerable population.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1717609","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T06:26:56Z","timestamp":1763360816000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Intersecting epidemics: immune dysregulation associated with HIV and tuberculosis syndemic contribute to increased risk of hypertensive disease in Sub-Saharan Africa"],"prefix":"10.3389","volume":"12","author":[{"given":"Pheletso","family":"Letuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Z.","family":"Zulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"B1","article-title":"Fact Sheets: Hypertension (2023)","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"177008","DOI":"10.1016\/j.ejphar.2024.177008","article-title":"Recent advancements in targeting the immune system to treat hypertension","volume":"983","author":"Muralitharan","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"J Hypertens"},{"key":"B4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3988\/jcn.2016.12.2.137","article-title":"Blood pressure in acute ischemic stroke","volume":"12","author":"McManus","year":"2016","journal-title":"J Clin Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","article-title":"Pathogenesis of hypertension","volume":"139","author":"Suzanne Oparil","year":"2003","journal-title":"Ann Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1093\/eurheartjsupp\/suac045","article-title":"May Measurement Month: results of 12 national blood pressure screening programmes between 2017 and 2019","volume":"24","author":"Poulter","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"B7","article-title":"Global Report on Hypertension: the Race Against a Silent Killer (2023)","year":""},{"key":"B8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41371-024-00913-6","article-title":"Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities","volume":"39","author":"Gafane-Matemane","year":"2024","journal-title":"J Hum Hypertens"},{"key":"B9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.3390\/ijerph18105445","article-title":"Mapping the burden of hypertension in South Africa: a comparative analysis of the national 2012 SANHANES and the 2016 demographic and health survey","volume":"18","author":"Ngianga-Bakwin Kandala","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100986","DOI":"10.1016\/j.ssmph.2021.100986","article-title":"Race, geographical location and other risk factors for hypertension: South African national health and nutrition examination survey 2011\/12","volume":"16","author":"Reddy","year":"2021","journal-title":"SSM Popul Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2021.12.006","article-title":"Serum potassium concentration and its association with hypertension among Ghanaian migrants and non-migrants: the RODAM study","volume":"342","author":"Ndong","year":"2022","journal-title":"Atherosclerosis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/aam.aam_1_17","article-title":"Urbanization, cities, and health: the challenges to Nigeria\u2014a review","volume":"16","author":"Aliyu","year":"2017","journal-title":"Ann Afr Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0265722","DOI":"10.1371\/journal.pone.0265722","article-title":"Prevalence of and factors associated with hypertension, diabetes, stroke and heart attack multimorbidity in Botswana: evidence from STEPS 2014 survey","volume":"17","author":"Ntiyani","year":"2022","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2147\/PPA.S306885","article-title":"The nexus between adherence to recommended lifestyle behaviors and blood pressure control in hypertensive patients at mutare provincial hospital, Zimbabwe: a cross-sectional study","volume":"15","author":"Tozivepi","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"B16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41371-018-0125-3","article-title":"Predictors of hypertension awareness, treatment and control in South Africa: results from the WHO-SAGE population survey (wave 2)","volume":"33","author":"Ware","year":"2019","journal-title":"J Hum Hypertens"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0204344","DOI":"10.1371\/journal.pone.0204344","article-title":"Prevalence and predictors of hypertension in Namibia: a national-level cross-sectional study","volume":"13","author":"Craig","year":"2018","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12889-020-8386-5","article-title":"Prevalence and associated factors of hypertension among adults in Gadarif in Eastern Sudan: a community-based study","volume":"20","author":"Omar","year":"2020","journal-title":"BMC Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12872-021-01983-x","article-title":"Prevalence and associated factors of hypertension among adults with diabetes mellitus in Northern Sudan: a cross-sectional study","volume":"21","author":"Abdelbagi","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1186\/s12889-021-12204-7","article-title":"Rural-urban variation in hypertension among women in Ghana: insights from a national survey","volume":"21","author":"Appiah","year":"2021","journal-title":"BMC Public Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1186\/s12889-020-09829-5","article-title":"Hypertension prevalence, awareness, treatment, and control and predicted 10-year CVD risk: a cross-sectional study of seven communities in East and West Africa (SevenCEWA)","volume":"20","author":"Okello","year":"2020","journal-title":"BMC Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41371-023-00833-x","article-title":"Prevalence of hypertension in a rural community in southeastern Nigeria; an opportunity for early intervention","volume":"37","author":"Ezeala-Adikaibe","year":"2023","journal-title":"J Hum Hypertens"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1161\/HYPERTENSIONAHA.123.21174","article-title":"Incidence of new-onset hypertension post\u2013COVID-19: comparison with influenza","volume":"80","author":"Zhang","year":"2023","journal-title":"Hypertension"},{"key":"B24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12916-024-03328-9","article-title":"Incidence of new-onset hypertension before, during, and after the COVID-19 pandemic: a 7-year longitudinal cohort study in a large population","volume":"22","author":"Trimarco","year":"2024","journal-title":"BMC Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0172089","DOI":"10.1371\/journal.pone.0172089","article-title":"Incidence and risk factors for hypertension among HIV patients in rural Tanzania\u2014a prospective cohort study","volume":"12","author":"Rodr\u00edguez-Arbol\u00ed","year":"2017","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.4102\/phcfm.v17i1.4813","article-title":"Prevalence of hypertension and associated factors in people living with HIV at senkatana clinic Maseru","volume":"17","author":"Selebalo","year":"2025","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e075176","DOI":"10.1136\/bmjopen-2023-075176","article-title":"Tuberculosis infection and hypertension: prevalence estimates from the US national health and nutrition examination survey","volume":"14","author":"Salindri","year":"2024","journal-title":"medRxiv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.amjmed.2023.09.015","article-title":"Controversies in hypertension V: resistant and refractory hypertension","volume":"137","author":"Edward J Filippone","year":"2024","journal-title":"Am J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.ackd.2019.03.002","article-title":"Resistant hypertension: diagnosis and management","volume":"26","author":"Nagarajan","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6698384","DOI":"10.1155\/2023\/6698384","article-title":"Risky sexual behaviour among HIV-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"2023","author":"Wondmeneh","year":"2023","journal-title":"Biomed Res Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e07750","DOI":"10.1016\/j.heliyon.2021.e07750","article-title":"Time to hypertension development among people living with HIV in South Africa: a longitudinal analysis of the national income dynamics survey (NIDS)","volume":"7","author":"Godongwana","year":"2021","journal-title":"Heliyon"},{"key":"B34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijid.2016.12.016","article-title":"Tuberculosis and hypertension\u2014a systematic review of the literature","volume":"56","author":"Seegert","year":"2017","journal-title":"Int J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"100690","DOI":"10.1016\/j.lanhl.2025.100690","article-title":"The prevalence, incidence, and sociodemographic risk factors of\u00a0HIV among older adults in sub-Saharan Africa (AWI-Gen): a\u00a0multicentre, longitudinal cohort study","volume":"6","author":"Olubayo","year":"2025","journal-title":"Lancet Healthy Longev"},{"key":"B36","volume-title":"HIV Statistics, Globally and by WHO Region","year":"2023"},{"key":"B37","volume-title":"Staff, Global Tuberculosis Report 2013","year":"2013"},{"key":"B38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/QAI.0b013e31827303d5","article-title":"Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering","volume":"61","author":"Kim","year":"2012","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cjca.2020.01.013","article-title":"Inflammation in hypertension","volume":"36","author":"Xiao","year":"2020","journal-title":"Can J Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ajh\/hpu142","article-title":"The immunological basis of hypertension","volume":"27","author":"Rodriguez-Iturbe","year":"2014","journal-title":"Am J Hypertens"},{"key":"B41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/01.mnh.0000203189.57513.76","article-title":"Inflammation in hypertension","volume":"15","author":"Savoia","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1089\/gtmb.2015.0255","article-title":"Serum markers of endothelial dysfunction and inflammation increase in hypertension with prediabetes Mellitus","volume":"20","author":"Huang","year":"2016","journal-title":"Genet Test Mol Biomarkers"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"H404","DOI":"10.1152\/ajpheart.00247.2015","article-title":"Cross talk between AT1 receptors and toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus","volume":"310","author":"Biancardi","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCRESAHA.110.217299","article-title":"Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension","volume":"107","author":"Marvar","year":"2010","journal-title":"Circ Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.biopsych.2012.01.017","article-title":"T lymphocytes and vascular inflammation contribute to stress-dependent hypertension","volume":"71","author":"Marvar","year":"2012","journal-title":"Biol Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/cvr\/cvaa207","article-title":"Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation","volume":"117","author":"Ruggeri Barbaro","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e92801","DOI":"10.1172\/jci.insight.92801","article-title":"A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage","volume":"2","author":"Norlander","year":"2017","journal-title":"JCI Insight"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1002\/imt2.268","article-title":"Non-differential gut microbes contribute to hypertension and its severity through co-abundances: a multi-regional prospective cohort study","volume":"4","author":"Liu","year":"2025","journal-title":"iMeta"},{"key":"B50","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates T(H)17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1172\/JCI74084","article-title":"DC isoketal-modified proteins activate T cells and promote hypertension","volume":"124","author":"Kirabo","year":"2014","journal-title":"J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","article-title":"Immune and inflammatory mechanisms in hypertension","volume":"21","author":"Guzik","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/cvr\/cvy112","article-title":"Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide","volume":"114","author":"Loperena","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","article-title":"Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans","volume":"68","author":"Itani","year":"2016","journal-title":"Hypertension"},{"key":"B55","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41577-019-0160-5","article-title":"Immune mechanisms of hypertension","volume":"19","author":"Drummond","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J Exp Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"B59","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1161\/CIRCULATIONAHA.113.003364","article-title":"Dendritic cells in cardiovascular diseases","volume":"128","author":"Christ","year":"2013","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri1996","article-title":"Steady-state and inflammatory dendritic-cell development","volume":"7","author":"Shortman","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.930446","article-title":"Inhibition and genetic ablation of the B7\/CD28T-cell costimulation axis prevents experimental hypertension","volume":"122","author":"Vinh","year":"2010","journal-title":"Circulation"},{"key":"B63","first-page":"125","article-title":"Heterogeneity in the appearance and distribution of macrophage subsets and their possible involvement in hypertensive vascular lesions in rats","volume":"75","author":"Abumiya","year":"1996","journal-title":"Lab Invest"},{"key":"B64","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1161\/01.HYP.33.1.389","article-title":"Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension","volume":"33","author":"Mervaala","year":"1999","journal-title":"Hypertension"},{"key":"B65","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1161\/01.HYP.36.3.360","article-title":"CC Chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension","volume":"36","author":"Bush","year":"2000","journal-title":"Hypertension"},{"key":"B66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/01.HYP.25.1.132","article-title":"Monocyte infiltration and c-fms expression in hearts of spontaneously hypertensive rats","volume":"25","author":"Haller","year":"1995","journal-title":"Hypertension"},{"key":"B67","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/ajh\/7.2.177","article-title":"Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension","volume":"7","author":"Eng","year":"1994","journal-title":"Am J Hypertens"},{"key":"B68","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/jcbfm.1994.43","article-title":"Quantitation of perivascular monocytes and macrophages around cerebral blood vessels of hypertensive and aged rats","volume":"14","author":"Liu","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"B69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.trsl.2017.10.011","article-title":"Macrophages under pressure: the role of macrophage polarization in hypertension","volume":"191","author":"Harwani","year":"2018","journal-title":"Transl Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/ndt\/gfl008","article-title":"Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease","volume":"21","author":"Ulrich","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/j.ajkd.2008.03.023","article-title":"Associations of glomerular number and birth weight with clinicopathological features of African Americans and whites","volume":"52","author":"Hughson","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coph.2014.12.003","article-title":"Role of T lymphocytes in hypertension","volume":"21","author":"Zhang","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4T Cells: fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cophys.2020.09.016","article-title":"The role of inflammation in hypertension: novel concepts","volume":"19","author":"Patrick","year":"2021","journal-title":"Curr Opin Physiol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.113.00689","article-title":"Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension","volume":"62","author":"Youn","year":"2013","journal-title":"Hypertension"},{"key":"B77","article-title":"Health Topics: HIV (2025)","year":""},{"key":"B78","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cells12101351","article-title":"HIV\u2013host cell interactions","volume":"12","author":"Masenga","year":"2023","journal-title":"Cells"},{"key":"B79","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s13365-014-0287-x","article-title":"HIV-1 target cells in the CNS","volume":"21","author":"Joseph","year":"2015","journal-title":"J Neurovirol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/apc.2016.0100","article-title":"Human immunodeficiency virus immune cell receptors, coreceptors, and cofactors: implications for prevention and treatment","volume":"30","author":"Woodham","year":"2016","journal-title":"AIDS Patient Care STDS"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41577-025-01136-7","article-title":"Immune-mediated strategies to solving the HIV reservoir problem","volume":"25","author":"Kulpa","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12879-025-11158-0","article-title":"Serum sPD-1 as a marker of T cell exhaustion in ART-na\u00efve, ART-experienced, and intestinal parasite co-infected HIV-positive adults at the university of Gondar comprehensive specialized hospital, Northwest Ethiopia, 2024","volume":"25","author":"Wondmagegn","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol Rev"},{"key":"B85","doi-asserted-by":"publisher","first-page":"115750","DOI":"10.1016\/j.biopha.2023.115750","article-title":"HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. Maintaining triple therapy based on integrase inhibitors","volume":"168","author":"Mu\u00f1oz-Muela","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e41222","DOI":"10.1097\/MD.0000000000041222","article-title":"Influence of cytokines on the recovery trajectory of HIV patients on antiretroviral therapy: a review","volume":"104","author":"Obeagu","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1172\/JCI136227","article-title":"The multifaceted nature of HIV latency","volume":"130","author":"Dufour","year":"2020","journal-title":"J Clin Invest"},{"key":"B88","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrmicro2848","article-title":"Microbial translocation in HIV infection: causes, consequences and treatment opportunities","volume":"10","author":"Sandler","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e1003174","DOI":"10.1371\/journal.ppat.1003174","article-title":"Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies","volume":"9","author":"Eriksson","year":"2013","journal-title":"PLoS Pathog"},{"key":"B90","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1437901","DOI":"10.3389\/fimmu.2024.1437901","article-title":"Characterizing the immune response to mycobacterium tuberculosis: a comprehensive narrative review and implications in disease relapse","volume":"15","author":"Rahman","year":"2024","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/cmi.2017.88","article-title":"Innate immunity in tuberculosis: host defense vs pathogen evasion","volume":"14","author":"Liu","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fmicb.2016.00328","article-title":"Innate immunity holding the flanks until reinforced by adaptive immunity against mycobacterium tuberculosis infection","volume":"7","author":"Khan","year":"2016","journal-title":"Front Microbiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20180325","article-title":"Type I interferons in tuberculosis: foe and occasionally friend","volume":"215","author":"Moreira-Teixeira","year":"2018","journal-title":"J Exp Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-alpha is required in the protective immune response against mycobacterium tuberculosis in mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1\u03b1 and IL-1\u03b2 production by distinct pulmonary myeloid subsets during mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.4049\/jimmunol.143.6.1851","article-title":"An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties","volume":"143","author":"Arend","year":"1989","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-\u03b3 horizon: biomarkers for immunodiagnosis of infection with mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1079990","DOI":"10.3389\/fpubh.2023.1079990","article-title":"Key populations and Sub-Saharan Africa\u2019s HIV response","volume":"11","author":"Moyo","year":"2023","journal-title":"Front Public Health"},{"key":"B102","doi-asserted-by":"publisher","first-page":"107050","DOI":"10.1016\/j.phrs.2023.107050","article-title":"Circulating cytokines and risk of developing hypertension: a systematic review and meta-analysis","volume":"200","author":"Caiazzo","year":"2024","journal-title":"Pharmacol Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11906-019-0956-5","article-title":"Patho-immune mechanisms of hypertension in HIV: a systematic and thematic review","volume":"21","author":"Masenga","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"B104","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B106","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s13365-012-0092-3","article-title":"Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy","volume":"18","author":"Cruse","year":"2012","journal-title":"J Neurovirol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"16858","DOI":"10.1038\/s41598-024-67703-5","article-title":"Hypertension among people living with human immunodeficiency virus in sub-saharan Africa: a systematic review and meta-analysis","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1006789","DOI":"10.3389\/fcvm.2022.1006789","article-title":"Sex differences in hypertension among people living with HIV after initiation of antiretroviral therapy","volume":"9","author":"Masenga","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1097\/HJH.0000000000001723","article-title":"Blood pressure and mortality in a prospective cohort of HIV-infected adults in Port-au-Prince, Haiti","volume":"36","author":"Batavia","year":"2018","journal-title":"J Hypertens"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/infdis\/jiz015","article-title":"HIV-related arterial stiffness in Malawian adults is associated with the proportion of PD-1-expressing CD8+ T cells and reverses with antiretroviral therapy","volume":"219","author":"Kelly","year":"2019","journal-title":"J Infect Dis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e42624","DOI":"10.1371\/journal.pone.0042624","article-title":"Relationship between microbial translocation and endothelial function in HIV infected patients","volume":"7","author":"Blodget","year":"2012","journal-title":"PLoS One"},{"key":"B112","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2011.06.001","article-title":"Lipopolysaccharide-binding protein (LBP) is associated with total and cardiovascular mortality in individuals with or without stable coronary artery disease\u2013results from the Ludwigshafen Risk and Cardiovascular Health Study (LURIC)","volume":"219","author":"Lepper","year":"2011","journal-title":"Atherosclerosis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1161\/CIRCULATIONAHA.124.070538","article-title":"CD4+ T cells expressing viral proteins induce HIV-associated endothelial dysfunction and hypertension through interleukin 1\u03b1-mediated increases in endothelial NADPH oxidase 1","volume":"151","author":"Kress","year":"2025","journal-title":"Circulation"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e069280","DOI":"10.1136\/bmjopen-2022-069280","article-title":"Association between HIV and treatment-resistant hypertension in Malawian adults: a protocol for a case-control study","volume":"13","author":"Gondwe","year":"2023","journal-title":"BMJ Open"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1235180","DOI":"10.3389\/fpubh.2023.1235180","article-title":"Prevalence of tuberculosis among prisoners in sub-Saharan Africa: a systematic review and meta-analysis","volume":"11","author":"Sisay Asgedom","year":"2023","journal-title":"Front Public Health"},{"key":"B116","volume-title":"Tuberculosis and Diabetes: Investment for Impact","year":"2023"},{"key":"B117","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40794-015-0014-5","article-title":"Tuberculosis and cardiovascular disease: linking the epidemics","volume":"1","author":"Huaman","year":"2015","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"B118","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrneph.2013.248","article-title":"Autoimmunity in the pathogenesis of hypertension","volume":"10","author":"Rodr\u00edguez-Iturbe","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bjid.2014.02.006","article-title":"Effect of pulmonary hypertension on outcome of pulmonary tuberculosis","volume":"18","author":"Marjani","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/qjmed\/hcu220","article-title":"The risk of chronic kidney disease in tuberculosis: a population-based cohort study","volume":"108","author":"Shen","year":"2015","journal-title":"QJM: Int J Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000463780","article-title":"Pathogenesis and treatment of hypertension in renal Tuberculosis","volume":"10","author":"Studer","year":"1984","journal-title":"Eur Urol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jinf.2023.03.020","article-title":"Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas","volume":"86","author":"Wang","year":"2023","journal-title":"J Infect"},{"key":"B123","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/CIRCULATIONAHA.109.849455","article-title":"Insights into the role of infection in atherogenesis and in plaque rupture","volume":"119","author":"Epstein","year":"2009","journal-title":"Circulation"},{"key":"B124","doi-asserted-by":"publisher","first-page":"102063","DOI":"10.1016\/j.rmcr.2024.102063","article-title":"Tuberculosis presenting as uncontrolled hypertension","volume":"50","author":"Mehta","year":"2024","journal-title":"Respir Med Case Rep"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e1372","DOI":"10.1016\/S2214-109X(23)00239-5","article-title":"The met and unmet health needs for HIV, hypertension, and diabetes in rural KwaZulu-natal, South Africa: analysis of a cross-sectional multimorbidity survey","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"B126","doi-asserted-by":"publisher","first-page":"4103604","DOI":"10.1155\/2019\/4103604","article-title":"Hypertension in HIV-infected patients receiving antiretroviral therapy in northeast Ethiopia","volume":"2019","author":"Fiseha","year":"2019","journal-title":"Int J Hypertens"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B128","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12939-017-0622-y","article-title":"Non-communicable diseases and related risk behaviors among men and women living with HIV in Cambodia: findings from a cross-sectional study","volume":"16","author":"Chhoun","year":"2017","journal-title":"Int J Equity Health"},{"key":"B129","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/HYPERTENSIONAHA.118.10893","article-title":"Hypertension in HIV-infected adults: novel pathophysiologic mechanisms","volume":"72","author":"Fahme","year":"2018","journal-title":"Hypertension"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/00004872-200307000-00028","article-title":"Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome","volume":"21","author":"Gazzaruso","year":"2003","journal-title":"J Hypertens"},{"key":"B131","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/01.aids.0000171410.76607.f8","article-title":"Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003","volume":"19","author":"Seaberg","year":"2005","journal-title":"AIDS"},{"key":"B132","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI200316261","article-title":"HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages","volume":"111","author":"Dressman","year":"2003","journal-title":"J Clin Invest"},{"key":"B133","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can J Cardiol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/apc.2016.0140","article-title":"Prevalence of metabolic syndrome among people living with HIV in developing countries: a systematic review","volume":"31","author":"Naidu","year":"2017","journal-title":"AIDS Patient Care STDS"},{"key":"B135","article-title":"Tuberculosis (2023)","year":""},{"key":"B136","doi-asserted-by":"publisher","first-page":"e49701","DOI":"10.7759\/cureus.49701","article-title":"Assessing the effect of the anti-tuberculosis drug rifampicin on known hypertensive patients with tuberculosis in a tertiary care center","volume":"15","author":"Yogesh","year":"2023","journal-title":"Cureus"},{"key":"B137","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4103\/0971-4065.176145","article-title":"Rifampicin and anti-hypertensive drugs in chronic kidney disease: pharmacokinetic interactions and their clinical impact","volume":"26","author":"Agrawal","year":"2016","journal-title":"Indian J Nephrol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e0297224","DOI":"10.1371\/journal.pone.0297224","article-title":"Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: a five-year prospective cohort analysis","volume":"19","author":"Dawood","year":"2024","journal-title":"PLoS One"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1717609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T06:26:58Z","timestamp":1763360818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1717609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":138,"alternative-id":["10.3389\/fcvm.2025.1717609"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1717609","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"article-number":"1717609"}}